rivastigmine has been researched along with Depression in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azulay, JP; Bordet, R; Defebvre, L; Defer, G; Delliaux, M; Destée, A; Devos, D; Duhamel, A; Dujardin, K; Eusebio, A; Kreisler, A; Krystkowiak, P; Lefaucheur, R; Maltête, D; Moreau, C; Ouk, T; Witjas, T | 1 |
| Attar, M; Caltagirone, C; Colombo, D; Cravello, L; Padovani, A; Sorbi, S; Spalletta, G | 1 |
| Fukunaga, K; Islam, MR; Moriguchi, S; Tagashira, H | 1 |
| Osborn, GG; Saunders, AV | 1 |
| Gray, SL; McDermott, CL | 1 |
| Alvarez, AM; Andrade, FC; Avila, R; Bottino, CM; Bustamante, SE; Câmargo, CH; Carvalho, IA; Hototian, SR; Saffi, F; Zukauskas, PR | 1 |
| Basun, H; Cederholm, T; Eriksdotter-Jönhagen, M; Faxén-Irving, G; Freund-Levi, Y; Garlind, A; Grut, M; Palmblad, J; Vedin, I; Wahlund, LO | 1 |
| Lacomblez, L | 1 |
2 review(s) available for rivastigmine and Depression
| Article | Year |
|---|---|
Current treatments for patients with Alzheimer disease.
Topics: Aggression; Alzheimer Disease; Behavior Therapy; Cholinesterase Inhibitors; Depression; Excitatory Amino Acid Antagonists; Galantamine; Health Status; Humans; Memantine; Neuroprotective Agents; Parasympathomimetics; Phenylcarbamates; Psychomotor Agitation; Psychotherapy; Psychotic Disorders; Rivastigmine; Time Factors; United States; United States Food and Drug Administration | 2010 |
Cholinesterase inhibitor adjunctive therapy for cognitive impairment and depressive symptoms in older adults with depression.
Topics: Antidepressive Agents; Cholinesterase Inhibitors; Cognition Disorders; Depression; Donepezil; Drug Therapy, Combination; Galantamine; Humans; Indans; Phenylcarbamates; Piperidines; Rivastigmine | 2012 |
3 trial(s) available for rivastigmine and Depression
| Article | Year |
|---|---|
Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial.
Topics: Activities of Daily Living; Adult; Aged; Apathy; Cholinesterase Inhibitors; Dementia; Depression; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Phenylcarbamates; Prospective Studies; Rivastigmine; Severity of Illness Index | 2014 |
Cognitive rehabilitation combined with drug treatment in Alzheimer's disease patients: a pilot study.
Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Anxiety; Caregivers; Cholinesterase Inhibitors; Cognition Disorders; Cognitive Behavioral Therapy; Depression; Female; Humans; Male; Mental Status Schedule; Middle Aged; Phenylcarbamates; Pilot Projects; Rivastigmine; Treatment Outcome | 2005 |
Omega-3 supplementation in mild to moderate Alzheimer's disease: effects on neuropsychiatric symptoms.
Topics: Activities of Daily Living; Aged; Alzheimer Disease; Analysis of Variance; Apolipoproteins E; Cholinesterase Inhibitors; Depression; Dietary Supplements; Donepezil; Double-Blind Method; Fatty Acids, Omega-3; Female; Galantamine; Genotype; Humans; Indans; Male; Phenylcarbamates; Piperidines; Psychiatric Status Rating Scales; Rivastigmine; Statistics, Nonparametric; Treatment Outcome | 2008 |
3 other study(ies) available for rivastigmine and Depression
| Article | Year |
|---|---|
Cognitive and affective changes in mild to moderate Alzheimer's disease patients undergoing switch of cholinesterase inhibitors: a 6-month observational study.
Topics: Alzheimer Disease; Apathy; Cholinesterase Inhibitors; Cognitive Dysfunction; Depression; Drug Substitution; Humans; Italy; Mood Disorders; Phenylcarbamates; Rivastigmine; Socioeconomic Factors | 2014 |
Rivastigmine improves hippocampal neurogenesis and depression-like behaviors via 5-HT1A receptor stimulation in olfactory bulbectomized mice.
Topics: Animals; Behavior, Animal; Depression; Hippocampus; Long-Term Potentiation; Male; Mice; Neurogenesis; Olfactory Bulb; Phenylcarbamates; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Rivastigmine | 2014 |
[Drug therapy strategies in Alzheimer's disease].
Topics: Aggression; Alzheimer Disease; Anti-Anxiety Agents; Antidepressive Agents; Antipsychotic Agents; Carbamates; Cholinesterase Inhibitors; Clinical Trials as Topic; Cognition Disorders; Depression; Donepezil; Humans; Indans; Mental Disorders; Neuroprotective Agents; Nootropic Agents; Phenylcarbamates; Piperidines; Rivastigmine; Sleep Wake Disorders; Tacrine | 1998 |